Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesPsychopharmacology Curriculum Field Test
Academic Psychiatry, 10/16/09
Zisook S et al. – The results of the field trial suggest that a dynamic, adult–centered curriculum that is exciting, innovative, and informative enough for a wide variety of programs can be developed; however, the development and programmatic barriers require considerable time and effort to overcome.
Related Articles
Teaching Pearls from the Lost Art of Psychopharmacology
Journal of Psychiatric Practice, 10/01/09
Relevance Score: 90%
Psychiatric treatments in dermatology: an update
Clinical and Experimental Dermatology, 11/16/09
Relevance Score: 80%
Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review
British Journal of Psychiatry, 11/09/09
Relevance Score: 80%
Today in Major Studies...keeping you current
Receive free subspecialty "5-minute updates" via email
Carboplatin-Pemetrexed Adjuvant Chemotherapy in Resected Non-small Cell Lung Cancer (NSCLC): A Phase II Study
Anticancer Research, 11/16/09
Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkins Lymphoma
Cephalon, 11/06/09
Mycophenolate mofetil: An update
Drugs of Today, 11/05/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial
European Journal of Neurology, 11/21/09
Metabolic Alterations During Valproic Acid Treatment: A Prospective Study
Pediatric Neurology , 11/21/09
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
Neurology, 11/20/09
Sponsor
Article Search
Sponsor